Liegl R - Search Results

1

Short-term real-world outcomes following intravitreal brolucizumab for neovascular AMD: SHIFT study.

Bulirsch LM, Saßmannshausen M, Nadal J, Liegl R, Thiele S, Holz FG. Bulirsch LM, et al. Among authors: liegl r. Br J Ophthalmol. 2022 Sep;106(9):1288-1294. doi: 10.1136/bjophthalmol-2020-318672. Epub 2021 Apr 12. Br J Ophthalmol. 2022. PMID: 33846161 Free PMC article.

2

Sorafenib prevents human retinal pigment epithelium cells from light-induced overexpression of VEGF, PDGF and PlGF.

Kernt M, Neubauer AS, Liegl RG, Hirneiss C, Alge CS, Wolf A, Ulbig MW, Kampik A. Kernt M, et al. Among authors: liegl rg. Br J Ophthalmol. 2010 Nov;94(11):1533-9. doi: 10.1136/bjo.2010.182162. Br J Ophthalmol. 2010. PMID: 20962354 Free article.

3

Axitinib modulates hypoxia-induced blood-retina barrier permeability and expression of growth factors.

Kernt M, Thiele S, Liegl RG, Kernt B, Eibl K, Haritoglou C, Ulbig MW, Kampik A. Kernt M, et al. Growth Factors. 2012 Feb;30(1):49-61. doi: 10.3109/08977194.2011.639300. Epub 2011 Dec 15. Growth Factors. 2012. PMID: 22168366

4

[Multikinase inhibitors as a new approach in neovascular age-related macular degeneration (AMD) treatment: in vitro safety evaluations of axitinib, pazopanib and sorafenib for intraocular use].

Thiele S, Liegl RG, König S, Siedlecki J, Langer J, Eibl K, Haritoglou C, Kampik A, Kernt M. Thiele S, et al. Among authors: liegl rg. Klin Monbl Augenheilkd. 2013 Mar;230(3):247-54. doi: 10.1055/s-0032-1328161. Epub 2013 Mar 18. Klin Monbl Augenheilkd. 2013. PMID: 23508753 German.

5

Combined VEGF and PDGF inhibition for neovascular AMD: anti-angiogenic properties of axitinib on human endothelial cells and pericytes in vitro.

Siedlecki J, Wertheimer C, Wolf A, Liegl R, Priglinger C, Priglinger S, Eibl-Lindner K. Siedlecki J, et al. Among authors: liegl r. Graefes Arch Clin Exp Ophthalmol. 2017 May;255(5):963-972. doi: 10.1007/s00417-017-3595-z. Epub 2017 Feb 4. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 28161830

6

Schiefelbein J, Müller M, Kern C, Herold T, Liegl R, Fasler K, Jeliazkova D, Priglinger S, Kortuem KU. Schiefelbein J, et al. Among authors: liegl r. Eur J Ophthalmol. 2020 Nov;30(6):1410-1417. doi: 10.1177/1120672119899627. Epub 2020 Jan 14. Eur J Ophthalmol. 2020. PMID: 31937122

7

Incidence of retinopathy of prematurity in Germany: evaluation of current screening criteria.

Larsen PP, Müller A, Lagrèze WA, Holz FG, Stahl A, Krohne TU; German Retina.net ROP Registry Study Group. Larsen PP, et al. Arch Dis Child Fetal Neonatal Ed. 2021 Mar;106(2):189-193. doi: 10.1136/archdischild-2020-319767. Epub 2020 Sep 28. Arch Dis Child Fetal Neonatal Ed. 2021. PMID: 32989047

8

Anti-angiogenic properties of rapamycin on human retinal pericytes in an in vitro model of neovascular AMD via inhibition of the mTOR pathway.

Asani B, Siedlecki J, Wertheimer C, Liegl R, Wolf A, Ohlmann A, Priglinger S, Priglinger C. Asani B, et al. Among authors: liegl r. BMC Ophthalmol. 2022 Mar 25;22(1):138. doi: 10.1186/s12886-022-02334-w. BMC Ophthalmol. 2022. PMID: 35337287 Free PMC article.

9

[Focal choroidal excavation (FCE)-More common than assumed?].

Weber C, Herrmann P, Holz FG, Liegl R. Weber C, et al. Among authors: liegl r. Ophthalmologie. 2022 Dec;119(12):1304-1308. doi: 10.1007/s00347-022-01636-0. Epub 2022 Apr 20. Ophthalmologie. 2022. PMID: 35441851 German. No abstract available.

10

Impact of COVID-19 before and after 2020 on Retinal Detachment Management in a Tertiary Eye Hospital in Germany.

Weber C, Stasik I, Holz FG, Liegl R. Weber C, et al. Among authors: liegl r. Ophthalmologica. 2022;245(6):577-587. doi: 10.1159/000526171. Epub 2022 Sep 8. Ophthalmologica. 2022. PMID: 36075203 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page